{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:54:03Z","timestamp":1793127243758,"version":"4.5.0"},"reference-count":28,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2019,11,30]]},"abstract":"<jats:p>Ischemic diseases are characterized by reduced blood supply to a tissue or an organ due to obstruction of blood vessels. The most serious and most common ischemic diseases include ischemic heart disease, ischemic stroke, and critical limb ischemia. Revascularization is the first choice of therapy, but the cell therapy is being introduced as a possible way of treatment for no-option patients. One of the possibilities of cell therapy is the use of mesenchymal stem cells (MSCs). MSCs are easily isolated from bone marrow and can be defined as non-hematopoietic multipotent adult stem cells population with a defined capacity for self-renewal and differentiation into cell types of all three germ layers depending on their origin. Since 1974, when Friedenstein and coworkers (Friedenstein et al. 1974) first time isolated and characterized MSCs, MSC-based therapy has been shown to be safe and effective. Nevertheless, many scientists and clinical researchers want to improve the success of MSCs in regenerative therapy. The secret of successful cell therapy may lie, along with the homing, in secretion of biologically active molecules including cytokines, growth factors, and chemokines known as MSCs secretome. One of the intracellular signalling mechanism includes the activity of phosphatidylinositol-3-kinase (phosphoinositide 3-kinase) (PI3K) - protein kinase B (serine-threonine protein kinase Akt) (Akt) pathway. This PI3K\/Akt pathway plays key roles in many cell types in regulating cell proliferation, differentiation, apoptosis, and migration. Pre-conditioning of MSCs could improve efficacy of signalling mechanism.<\/jats:p>","DOI":"10.33549\/physiolres.934345","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T04:55:40Z","timestamp":1576472140000},"page":"S131-S138","source":"Crossref","is-referenced-by-count":137,"title":["The PI3k\/Akt Pathway Is Associated With Angiogenesis, Oxidative Stress and Survival of Mesenchymal Stem Cells in Pathophysiologic Condition in Ischemia"],"prefix":"10.33549","author":[{"given":"A.","family":"SAMAKOVA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"GAZOVA","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"SABOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"VALASKOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"JURIKOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"KYSELOVIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2019,11,30]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"ABOYANS V, RICCO JB, BARTELINK M-LEL, BJ\u00d6RCK M, BRODMANN M, COHNERT T, COLLET JP, CZERNY M, DE CARLO M, DEBUS S, ESPINOLA-KLEIN C, KAHAN T, KOWNATOR S, MAZZOLAI L, NAYLOR AR, ROFFI M, R\u00d6THER J, SPRYNGER M, TENDERA M, TEPE G, VENERMO M, VLACHOPOULOS C, DESORMAIS I, DOCUMENT REVIEWERS: 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Heart Journal, 2017.","DOI":"10.5603\/kp.2017.0216"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"BECKWITT CH, BRUFSKY A, OLTVAI ZN, WELLS A: Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Res 20: 144-155, 2018.","DOI":"10.1186\/s13058-018-1066-z"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"CARSON RA, RUDINE AC, TALLY SJ, FRANKS AL, FRAHM KA, WALDMAN JK, SILSWAL N, BURALE S, PHAN JV, CHANDRAN UR, MONAGHAN AP, DEFRANCO DB: Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms. PLOS ONE 13: e0196387, 2018.","DOI":"10.1371\/journal.pone.0196387"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"FERREIRA JR, TEIXEIRA GQ, SANTOS SG, BARBOSA MA, ALMEIDA-PORADA D, GON\u00c7ALVES RM: Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning. Frontiers in Immunology 9: 2837, 2018.","DOI":"10.3389\/fimmu.2018.02837"},{"key":"ref4","unstructured":"FRIEDENSTEIN AJ, DERIGLAZOVA UF, KULAGINA NN, PANASUK AF, RUDAKOWA SF, LURI\u00c1 EA, RUADKOW IA: Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2: 83-92, 1974."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"GAZZERRO P, PROTO M C, GANGEMI G, MALFITANO AM, CIAGLIA E, PISANTI S, SANTORO A, LAEZZA C, BIFULCO M. Pharmacological actions of statins: a critical appraisal in the management of cancer. Pharmacol Rev 64:102-146, 2012.","DOI":"10.1124\/pr.111.004994"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"GNECCHI M, ZHANG Z, NI A, DZAU VJ: Paracrine mechanisms in adult stem cell signaling and therapy. Circul Res 11: 1204-1219, 2008.","DOI":"10.1161\/circresaha.108.176826"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"GOC A, KOCHUPARAMBIL ST, AL-HUSEIN B, AL-AZAYZIH A, MOHAMAD A, SOMANATH P R: Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis. BMC Cancer 12: 409, 2012.","DOI":"10.1186\/1471-2407-12-409"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"CHEN J, CRAWFORD R, CHEN C, XIAO Y: The key regulatory roles of the PI3K\/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration. Tissue Eng Part B Rev 19: 516-528, 2013.","DOI":"10.1089\/ten.teb.2012.0672"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"KARIMINEKOO S, MOVASSAGHPOUR A, RAHIMZADEH A, TALEBI M, SHAMSASENJAN K, AKBARZADEH A: Implications of mesenchymal stem cells in regenerative medicine. Artif Cells Nanomed Biotechnol 44: 749-757, 2016.","DOI":"10.3109\/21691401.2015.1129620"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"KASTRUP J, MYGIND ND, QAYYUM AA, MATHIASEN AB, HAACK-S\u00d8RENSEN M, EKBLOND A: Mesenchymal stromal cell therapy in ischemic heart disease. Scand Cardiovasc J 50: 293-299, 2016.","DOI":"10.1080\/14017431.2016.1210213"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"KODE JA, MUKHERJEE S, JOGLEKAR MV, HARDIKAR AA: Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11: 377-391, 2009.","DOI":"10.1080\/14653240903080367"},{"key":"ref12","unstructured":"MAHLA R.S: Stem Cells Applications in Regenerative Medicine and Disease. Therapeutics. International Journal of Cell Biology 2016: 1-24, 2016."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"MANGI AA, NOISEUX N, KONG, HE H, REZVANI M, INGWALL JS, DZAU VJ: Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nature Med 9: 1195-1201, 2003.","DOI":"10.1038\/nm912"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"MEIRELLES LDA S, FONTES AM, COVAS DT, CAPLAN AI: Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20: 419-427, 2009.","DOI":"10.1016\/j.cytogfr.2009.10.002"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"OSAKI M, OSHIMURA M, ITO H: PI3K-Akt pathway: Its functions and alterations in human cancer. Apoptosis 9: 667-676, 2004","DOI":"10.1023\/b:appt.0000045801.15585.dd"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"SANDHU K, MAMAS M, BUTLER R: Endothelial progenitor cells: Exploring the pleiotropic effects of statins. World J Cardiol 9: 1-13, 2017.","DOI":"10.4330\/wjc.v9.i1.1"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"SINGH A, SINGH A, SEN D: Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010\u20132015). Stem Cell Res Ther 7: 82, 2016.","DOI":"10.1186\/s13287-016-0341-0"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"SOBACCHI C, PALAGANO E, VILLA A, MENALE C: Soluble factors on stage to direct mesenchymal stem cells fate. Front Bioeng Biotechnol 5: 32, 2017.","DOI":"10.3389\/fbioe.2017.00032"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"UCCIOLI L, MELONI M, IZZO V, GIURATO L, MEROLLA S, GANDINI R: Critical limb ischemia: current challenges and future prospects. Vasc Health Risk Manag 14: 63-74, 2018.","DOI":"10.2147\/vhrm.s125065"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"WANG XL, QI J, SHI YQ, LU ZY, LI RL, HUANG GJ, NING BB, HAO LS, WANG H, HAO CN, LI Y, ZHOU HS, DUAN JL: Atorvastatin plus therapeutic ultrasound improve postnatal neovascularization in response to hindlimb ischemia via the PI3K-Akt pathway. Am J Transl Res 5: 2877-2886, 2019.","DOI":"10.1136\/heartjnl-2014-307109.72"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"WOOD WG, IGBAVBOA U, MULLER WE, ECKERT GP: Statins, Bcl-2, and apoptosis: cell death or cell protection? Mol Neurobiol 48: 308-314, 2013.","DOI":"10.1007\/s12035-013-8496-5"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"XU H, YANG YJ, YANG T, QIAN HY: Statins and stem cell modulation. Ageing Res Rev 12: 1-7, 2013.","DOI":"10.1016\/j.arr.2012.03.006"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"YONG KW, CHOI JR, MOHAMMADI M, MITHA AP, SANATI-NEZHAD A, SEN A: Mesenchymal stem cell therapy for ischemic tissues. Stem Cells Int 2018: 1-12, 2018.","DOI":"10.1155\/2018\/8179075"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"YOUSSEF A, ABOALOLA D, HAN VKM: The roles of insulin-like growth factors in mesenchymal stem cell niche. Stem Cells Int 2017: 1-12, 2017.","DOI":"10.1155\/2017\/9453108"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Z\u00c1LE\u0160\u00c1K M, BLA\u017d\u00cd\u010cEK P, GABLOVSK\u00dd I, LEDV\u00c9NYIOV\u00c1 V, BARTEKOV\u00c1 M, ZIEGELH\u00d6FFER A, RAVINGEROV\u00c1 T: Impaired PI3K\/Akt signaling as a potential cause of failure to precondition rat hearts under conditions of simulated hyperglycemia. Physiol Res 64: 633-641, 2015.","DOI":"10.33549\/physiolres.932883"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Z\u00c1LE\u0160\u00c1K M, BLA\u017d\u00cd\u010cEK P, PANCZA D, GABLOVSK\u00dd I, \u0160TRB\u00c1K V, RAVINGEROV\u00c1 T: Hyperosmotic environment blunts effectivity of ischemic preconditioning against ischemia-reperfusion injury and improves ischemic tolerance in non-preconditioned isolated rat hearts. Physiol Res 65: 1045-1051, 2016.","DOI":"10.1093\/cvr\/cvu091.117"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"ZHOU Q, LIAO JK: Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Curr Pharm Des 15: 467-478, 2009.","DOI":"10.2174\/138161209787315684"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T06:23:27Z","timestamp":1613111007000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2019\/68_S131.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,30]]},"references-count":28,"URL":"https:\/\/doi.org\/10.33549\/physiolres.934345","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,30]]}}}